VENUNGOPAL, P.; BALAKRISHNAN, K.; SRIRAM, D. K.; GEORGE, M. INCLISIRAN (LEQVIO): A FIRST-IN-CLASS SMALL INTERFERING RNA THERAPEUTIC DRUG APPROVED BY FDA FOR TREATING PRIMARY HYPERCHOLESTEROLEMIA OR DYSLIPIDEMIA. Asian J Pharm Clin Res 2022, 15, 42-46.